EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mutational binding assessment for TCR engineering on experimental and AlphaFold 3 scaffolds

Zhongliang Guo, Kei Oyama, Rui Yamaguchi

Frontiers in Bioinformatics · 29.10.2026 · 6

DOI: 10.3389/fbinf.2026.1879274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioinformatics, online erschienen am 29.10.2026. Verfasst von Zhongliang Guo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Systems Biology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Machine learning-based binding affinity prediction can support T-cell receptor (TCR) engineering, but its reliability remains uncertain when experimental structures of TCRs bound to peptide–major histocompatibility complexes (pMHCs) are unavailable and predicted structures must be used instead. Here, we examined how AlphaFold 3 (AF3) scaffold choice and conformational sampling affect Δ Δ G -based prioritization of TCR–pMHC complementarity-determining region (CDR) mutations. Bound–unbound structural comparisons showed that pMHC binding is associated mainly with local CDR remodeling, especially in CDR3 loops, whereas TCR framework regions remain comparatively stable. AF3 generally recovered bound-like TCR conformations, but downstream Δ Δ G prediction performance depended strongly on both scaffold source and model architecture. These scaffold-dependent differences indicate that experimental structures remain the most reliable input when available, although such structures are rarely accessible in prospective TCR design settings. Among AF3-based inputs, Prompt-DDG and RDE-PPI were relatively robust to wild-type predicted scaffolds, whereas BA-DDG and H3-DDG benefited more from mutant-specific AF3 scaffolds evaluated by reverse-mutation scoring. Across four templates, AF3-mutant scaffolds gave the highest mean top-10 recovery among the AF3-based inputs for all four predictors. These results support using experimental structures when available and suggest using AF3-mutant scaffolds for recovering top-ranked CDR candidates when only predicted structures are available.

Schlagwörter

Stichwörter der Autor:innen

AlphaFold 3CDR engineeringT-cell receptorTCR–pMHCconformational ensemble

Autor:innen und Institutionen

  • Division of Cancer Systems Biology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.
  • Nagoya University School of Medicine, Nagoya, Aichi, Japan.
  • Division of Cancer Informatics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

Zitieren

APA

Guo, Z., Oyama, K., & Yamaguchi, R. (2026). Mutational binding assessment for TCR engineering on experimental and AlphaFold 3 scaffolds. Frontiers in Bioinformatics, 6. https://doi.org/10.3389/fbinf.2026.1879274

Vancouver

Guo Z, Oyama K, Yamaguchi R. Mutational binding assessment for TCR engineering on experimental and AlphaFold 3 scaffolds. Frontiers in Bioinformatics. 2026;6. doi:10.3389/fbinf.2026.1879274

BibTeX
@article{Guo2026,
  author = {Guo, Zhongliang and Oyama, Kei and Yamaguchi, Rui},
  title = {Mutational binding assessment for TCR engineering on experimental and AlphaFold 3 scaffolds},
  journal = {Frontiers in Bioinformatics},
  year = {2026},
  volume = {6},
  doi = {10.3389/fbinf.2026.1879274}
}
Kostenlos starten →